Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

HIV Infection

Free Subscription 25.06.2018 12 AIDS 4 AIDS Res Hum Retroviruses 7 Clin Infect Dis 1 Drugs 4 HIV Med 7 J Acquir Immune Defic Syndr 2 J Clin Invest 5 J Infect Dis 2 J Med Virol 3 J Virol 1 Lancet Glob Health 5 Lancet HIV 1 MMWR Morb Mortal Wkly Rep 1 Nature 16 PLoS One 2 PLoS Pathog 1 Proc Natl Acad Sci U S A 2 Science

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. VALVERDE EE, Beer L, Johnson CH, Baugher A, et al
   Changes in perceived discrimination in healthcare settings reported by HIV patients in the United States from 1996 to 2011-2013.
   AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001908.
   PubMed     Text format     Abstract available
   
   
2. CHHABRA S, Underwood J, Cole JH, Caan M, et al
   Clinical research cerebral MRI findings in HIV positive subjects and appropriate controls.
   AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001910.
   PubMed     Text format     Abstract available
   
   
3. RUBIN LH, Phan KL, Keating SM, Maki PM, et al
   A single low-dose of hydrocortisone enhances cognitive functioning in HIV-infected women.
   AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001930.
   PubMed     Text format     Abstract available
   
   
4. PETERS L, Laut K, Resnati C, Del Campo S, et al
   Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals.
   AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001928.
   PubMed     Text format     Abstract available
   
   
5. SOONTORNNIYOMKIJ V, Umlauf A, Soontornniyomkij B, Gouaux B, et al
   Association of antiretroviral therapy with brain aging changes among HIV-infected adults.
   AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001927.
   PubMed     Text format     Abstract available
   
   
6. RUEGAMER T, Hoffmann R, Rohrhofer A, Audebert F, et al
   Inhibition of HIV-1 infection by HPgV-1 derived peptides is affected by HPgV-1 genotype and HIV-1 coreceptor tropism.
   AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001926.
   PubMed     Text format     Abstract available
   
   
7. SAXENA V, Ghate M, Bichare S, Khan I, et al
   Increased degranulation of immune cells is associated with higher cervical viral load in HIV infected women.
   AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001925.
   PubMed     Text format     Abstract available
   
   
8. HU J, Geldsetzer P, Steele SJ, Matthews P, et al
   The impact of lay counselors on HIV testing rates: Quasi-experimental evidence from lay counselor redeployment in KwaZulu-Natal, South Africa.
   AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001924.
   PubMed     Text format     Abstract available
   
   
9. SIMMS V, Rylance S, Bandason T, Dauya E, et al
   CD4 count recovery following initiation of HIV antiretroviral therapy in older childhood and adolescence.
   AIDS. 2018 Jun 20. doi: 10.1097/QAD.0000000000001905.
   PubMed     Text format     Abstract available
   
   
10. HOY JF, Richardson R, Ebeling PR, Rojas J, et al
    Zoledronic acid is superior to tenofovir DF-switching for low bone mineral density in adults with HIV: a randomised trial.
    AIDS. 2018 Jun 20. doi: 10.1097/QAD.0000000000001911.
    PubMed     Text format     Abstract available
    
    
11. BERETTA M, Moreau A, Bouvin-Pley M, Essat A, et al
    Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains.
    AIDS. 2018 Jun 20. doi: 10.1097/QAD.0000000000001906.
    PubMed     Text format     Abstract available
    
    
12. CHAMPENOIS K, Seng R, Persoz A, Essat A, et al
    Recent trends in sexual behaviours among MSM followed since primary HIV-1 infection.
    AIDS. 2018 Jun 20. doi: 10.1097/QAD.0000000000001916.
    PubMed     Text format     Abstract available
    
    

    
    AIDS Res Hum Retroviruses

13. FLEMMING J, Wiesen L, Herschhorn A
    Conformation-dependent interactions between HIV-1 envelope glycoproteins and broadly neutralizing antibodies.
    AIDS Res Hum Retroviruses. 2018 Jun 15. doi: 10.1089/AID.2018.0102.
    PubMed     Text format     Abstract available
    
    
14. MACEDO AB, Resop RS, Martins LJ, Szaniawski MA, et al
    Influence of biological sex, age and HIV status in an in vitro primary cell model of HIV latency using a CXCR4 tropic virus.
    AIDS Res Hum Retroviruses. 2018 Jun 21. doi: 10.1089/AID.2018.0098.
    PubMed     Text format     Abstract available
    
    
15. KIM AA, Rehle T
    Assessing estimates of HIV incidence with recent infection testing algorithms that include viral load testing and antiretroviral therapy exposure status.
    AIDS Res Hum Retroviruses. 2018 Jun 21. doi: 10.1089/AID.2017.0316.
    PubMed     Text format     Abstract available
    
    
16. NICOLINI LA, Magne F, Signori A, Di Biagio A, et al
    HBV vaccination in HIV: immunogenicity and persistence of seroprotection up to 7 years following a primary immunization course.
    AIDS Res Hum Retroviruses. 2018 Jun 21. doi: 10.1089/AID.2017.0070.
    PubMed     Text format     Abstract available
    
    

    
    Clin Infect Dis

17. SVENSSON EM, Svensson RJ, Te Brake LHM, Boeree MJ, et al
    The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.
    Clin Infect Dis. 2018;67:34-41.
    PubMed     Text format     Abstract available
    
    
18. MORGAN E, Hohmann S, Ridgeway J, Daum R, et al
    Decreasing incidence of skin and soft tissue infections at 86 U.S. emergency departments, 2009-2014.
    Clin Infect Dis. 2018 Jun 15. pii: 5038434. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
19. GATELL JM, Assoumou L, Moyle G, Waters L, et al
    Immediate vs. Deferred Switching from a Boosted Protease Inhibitor (PI/r) Based Regimen to a Dolutegravir (DTG) Based Regimen in Virologically Suppressed Patients with High Cardiovascular Risk or Age >/=50 years: Final 96 Weeks Results of NEAT 022
    Clin Infect Dis. 2018 Jun 14. pii: 5038116. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
20. SHEPHERD L, Ryom L, Law M, Petoumenos K, et al
    Cessation of Cigarette Smoking and the Impact on Cancer Incidence in HIV-positive Persons: The D:A:D Study.
    Clin Infect Dis. 2018 Jun 14. pii: 5038118. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
21. HECTOR J, Vinikoor M, Chilengi R, Ehmer J, et al
    No Impact of Hepatitis B Virus Infection on Early Mortality among HIV-infected Patients in Southern Africa.
    Clin Infect Dis. 2018 Apr 18. pii: 4975531. doi: 10.1093.
    PubMed     Text format    
    
    
22. NOGUERA-JULIAN M, Gonzalez-Beiras C, Parera M, Kapa A, et al
    Aetiological Characterization of the Cutaneous Ulcer Syndrome in Papua New Guinea using Shotgun Metagenomics.
    Clin Infect Dis. 2018 Jun 16. pii: 5039156. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
23. PHILBIN MM, Feaster DJ, Gooden L, Duan R, et al
    The North-South divide: substance use risk, care engagement, and viral suppression among hospitalized HIV-infected patients in 11 U.S. cities.
    Clin Infect Dis. 2018 Jun 16. pii: 5039154. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Drugs

24. DEEKS ED
    Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection.
    Drugs. 2018 Jun 18. pii: 10.1007/s40265-018-0934.
    PubMed     Text format     Abstract available
    
    

    
    HIV Med

25. BROWN AE, Nash S, Connor N, Kirwan PD, et al
    Towards elimination of HIV transmission, AIDS and HIV-related deaths in the UK.
    HIV Med. 2018 Jun 20. doi: 10.1111/hiv.12617.
    PubMed     Text format     Abstract available
    
    
26. 
    Welcome Letter.
    HIV Med. 2018;19 Suppl 3:3.
    PubMed     Text format    
    
    
27. SMITH DE, Woolley IJ, Russell DB, Bisshop F, et al
    HIV in practice: current approaches and challenges in the diagnosis, treatment and management of HIV infection in Australia.
    HIV Med. 2018;19 Suppl 3:5-23.
    PubMed     Text format     Abstract available
    
    
28. MAO X, Wang Z, Hu Q, Huang C, et al
    HIV incidence is rapidly increasing with age among young men who have sex with men in China: a multicentre cross-sectional survey.
    HIV Med. 2018 Jun 19. doi: 10.1111/hiv.12623.
    PubMed     Text format     Abstract available
    
    

    
    J Acquir Immune Defic Syndr

29. HART SA, Vardhanabhuti S, Strobino SA, Harrison LJ, et al
    The Impact of Changes over Time in the Stanford University Genotypic Resistance Interpretation Algorithm.
    J Acquir Immune Defic Syndr. 2018 Jun 14. doi: 10.1097/QAI.0000000000001776.
    PubMed     Text format     Abstract available
    
    
30. GOH SM, Williams J, Pannu N, Costello K, et al
    Are Bone Disease and Cardiovascular Disease Risk Correlated in an HIV Cohort?
    J Acquir Immune Defic Syndr. 2018 Jun 12. doi: 10.1097/QAI.0000000000001771.
    PubMed     Text format    
    
    
31. CALVET GA, Brasil P, Siqueira AM, Zogbi HE, et al
    Zika Virus Infection and Differential Diagnosis in A Cohort of HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2018 Jun 14. doi: 10.1097/QAI.0000000000001777.
    PubMed     Text format     Abstract available
    
    
32. CAMPOS NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, et al
    Cost-effectiveness of cervical cancer screening in women living with HIV in South Africa: A mathematical modeling study.
    J Acquir Immune Defic Syndr. 2018 Jun 15. doi: 10.1097/QAI.0000000000001778.
    PubMed     Text format     Abstract available
    
    
33. KERKERIAN G, Kestler M, Carter A, Wang L, et al
    Attrition across the HIV cascade of care among a diverse cohort of women living with HIV in Canada.
    J Acquir Immune Defic Syndr. 2018 Jun 15. doi: 10.1097/QAI.0000000000001775.
    PubMed     Text format     Abstract available
    
    
34. PIERCE JD, Ylitalo KR, Lanning BA, Limbers CC, et al
    Sex Education and HIV Testing Among Young Men who Have Sex with Men: Findings From The 2006-2010 and 2011-2015 National Survey of Family Growth.
    J Acquir Immune Defic Syndr. 2018 Jun 12. doi: 10.1097/QAI.0000000000001773.
    PubMed     Text format     Abstract available
    
    
35. LALLEY-CHARECZKO L, Clark D, Conyngham SC, Zuppa A, et al
    Delivery of TDF/FTC for Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition in Young Adult Men Who Have Sex with Men and Transgender Women of Color using a Urine Adherence Assay.
    J Acquir Immune Defic Syndr. 2018 Jun 12. doi: 10.1097/QAI.0000000000001772.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Invest

36. SALANTES DB, Zheng Y, Mampe F, Srivastava T, et al
    HIV-1 latent reservoir size and diversity are stable following brief treatment interruption.
    J Clin Invest. 2018 Jun 18. pii: 120194. doi: 10.1172/JCI120194.
    PubMed     Text format     Abstract available
    
    
37. MOYSI E, Pallikkuth S, De Armas LR, Gonzalez LE, et al
    Altered immune cell follicular dynamics in HIV infection following influenza vaccination.
    J Clin Invest. 2018 Jun 18. pii: 99884. doi: 10.1172/JCI99884.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

38. MONTEJANO R, Stella-Ascariz N, Monge S, Bernardino JI, et al
    Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV-1 infected Adults.
    J Infect Dis. 2018 Jun 15. pii: 5038298. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
39. SHAN Z, Clish CB, Hua S, Scott JM, et al
    Gut Microbial-related Choline Metabolite Trimethylamine-N-oxide is Associated with Progression of Carotid Artery Atherosclerosis in HIV Infection.
    J Infect Dis. 2018 Jun 15. pii: 5038303. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
40. SHIPLEY MM, Renner DW, Ott M, Bloom DC, et al
    Genome-Wide Surveillance of Genital Herpes Simplex Virus Type 1 From Multiple Anatomic Sites Over Time.
    J Infect Dis. 2018 Jun 18. pii: 5039658. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
41. MESHER D, Panwar K, Thomas SL, Edmundson C, et al
    The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016.
    J Infect Dis. 2018 Jun 18. pii: 5025126. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
42. COTE HCF, Hsieh AYY
    Leukocyte telomere length in HIV infection: A marker of persistent immune aging or transient immune reconstitution?
    J Infect Dis. 2018 Jun 15. pii: 5038297. doi: 10.1093.
    PubMed     Text format    
    
    

    
    J Med Virol

43. KARKASHADZE E, Dvali N, Bolokadze N, Sharvadze L, et al
    Epidemiology of HIV drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia.
    J Med Virol. 2018 Jun 15. doi: 10.1002/jmv.25245.
    PubMed     Text format     Abstract available
    
    
44. DEGEFA B, Gebreeyesus T, Gebremedhin Z, Melkamu G, et al
    Prevalence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus among blood donors of Mekelle blood bank, Northern Ethiopia: A three year retrospective study.
    J Med Virol. 2018 Jun 15. doi: 10.1002/jmv.25248.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

45. BROCCA-COFANO E, Xu C, Wetzel KS, Cottrell ML, et al
    Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques.
    J Virol. 2018 Jun 20. pii: JVI.00576-18. doi: 10.1128/JVI.00576.
    PubMed     Text format     Abstract available
    
    
46. XU B, Pan Q, Liang C
    The role of MxB in interferon-alpha mediated inhibition of HIV-1 infection.
    J Virol. 2018 Jun 20. pii: JVI.00422-18. doi: 10.1128/JVI.00422.
    PubMed     Text format     Abstract available
    
    
47. MULLER JA, Glockle A, Gawanbacht A, Geyer M, et al
    Reduced Susceptibility to VIRIP-based HIV-1 Entry Inhibitors has a High Genetic Barrier and Severe Fitness Costs.
    J Virol. 2018 Jun 20. pii: JVI.00733-18. doi: 10.1128/JVI.00733.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Glob Health

48. WAHL B, O'Brien KL, Greenbaum A, Majumder A, et al
    Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15.
    Lancet Glob Health. 2018;6:e744-e757.
    PubMed     Text format     Abstract available
    
    

    
    Lancet HIV

49. HARRIS M
    What did we learn from the bictegravir switch studies?
    Lancet HIV. 2018 Jun 15. pii: S2352-3018(18)30099.
    PubMed     Text format    
    
    
50. DAAR ES, DeJesus E, Ruane P, Crofoot G, et al
    Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre
    Lancet HIV. 2018 Jun 15. pii: S2352-3018(18)30091.
    PubMed     Text format     Abstract available
    
    
51. MOLINA JM, Ward D, Brar I, Mills A, et al
    Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled,
    Lancet HIV. 2018 Jun 15. pii: S2352-3018(18)30092.
    PubMed     Text format     Abstract available
    
    
52. MARSHALL BDL, Goedel WC, King MRF, Singleton A, et al
    Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study.
    Lancet HIV. 2018 Jun 13. pii: S2352-3018(18)30097.
    PubMed     Text format     Abstract available
    
    
53. GOLUB SA, Enemchukwu CU
    The critical importance of retention in HIV prevention.
    Lancet HIV. 2018 Jun 13. pii: S2352-3018(18)30130.
    PubMed     Text format    
    
    

    
    MMWR Morb Mortal Wkly Rep

54. PITASI MA, Delaney KP, Oraka E, Bradley H, et al
    Interval Since Last HIV Test for Men and Women with Recent Risk for HIV Infection - United States, 2006-2016.
    MMWR Morb Mortal Wkly Rep. 2018;67:677-681.
    PubMed     Text format     Abstract available
    
    

    
    Nature

55. GIZZI AS, Grove TL, Arnold JJ, Jose J, et al
    A naturally occurring antiviral ribonucleotide encoded by the human genome.
    Nature. 2018 Jun 20. pii: 10.1038/s41586-018-0238.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

56. MEE P, Fearon E, Hassan S, Hensen B, et al
    The association between being currently in school and HIV prevalence among young women in nine eastern and southern African countries.
    PLoS One. 2018;13:e0198898.
    PubMed     Text format     Abstract available
    
    
57. AKOKU DA, Tihnje MA, Vukugah TA, Tarkang EE, et al
    Socio-economic vulnerabilities and HIV: Drivers of transactional sex among female bar workers in Yaounde, Cameroon.
    PLoS One. 2018;13:e0198853.
    PubMed     Text format     Abstract available
    
    
58. GESESEW HA, Ward P, Woldemichael K, Mwanri L, et al
    Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15.
    PLoS One. 2018;13:e0198815.
    PubMed     Text format     Abstract available
    
    
59. MEGGI B, Vojnov L, Mabunda N, Vubil A, et al
    Performance of point-of-care birth HIV testing in primary health care clinics: An observational cohort study.
    PLoS One. 2018;13:e0198344.
    PubMed     Text format     Abstract available
    
    
60. SU JR, Ng C, Lewis PW, Cano MV, et al
    Adverse events after vaccination among HIV-positive persons, 1990-2016.
    PLoS One. 2018;13:e0199229.
    PubMed     Text format     Abstract available
    
    
61. AGHAIZU A, Tosswill J, De Angelis D, Ward H, et al
    HIV incidence among sexual health clinic attendees in England: First estimates for black African heterosexuals using a biomarker, 2009-2013.
    PLoS One. 2018;13:e0197939.
    PubMed     Text format     Abstract available
    
    
62. METCALF T, Soria J, Montano SM, Ticona E, et al
    Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis.
    PLoS One. 2018;13:e0198695.
    PubMed     Text format     Abstract available
    
    
63. MEKONEN A, Ayele Y, Berhan Y, Woldeyohannes D, et al
    Factors which contributed for low quality sputum smears for the detection of acid fast bacilli (AFB) at selected health centers in Ethiopia: A quality control perspective.
    PLoS One. 2018;13:e0198947.
    PubMed     Text format     Abstract available
    
    
64. KENDALL CE, Shoemaker ES, Boucher L, Rolfe DE, et al
    The organizational attributes of HIV care delivery models in Canada: A cross-sectional study.
    PLoS One. 2018;13:e0199395.
    PubMed     Text format     Abstract available
    
    
65. LIMAYE NP, Blas MM, Alva IE, Carcamo CP, et al
    The Amazon Hope: A qualitative and quantitative assessment of a mobile clinic ship in the Peruvian Amazon.
    PLoS One. 2018;13:e0196988.
    PubMed     Text format     Abstract available
    
    
66. MIRKUZIE AH
    Implementation and outcomes of guideline revisions for the prevention of mother-to-child HIV transmission in Mother Support Programme, Addis Ababa, Ethiopia.
    PLoS One. 2018;13:e0198438.
    PubMed     Text format     Abstract available
    
    
67. WANG X, Bourne A, Liu P, Sun J, et al
    Understanding willingness to use oral pre-exposure prophylaxis for HIV prevention among men who have sex with men in China.
    PLoS One. 2018;13:e0199525.
    PubMed     Text format     Abstract available
    
    
68. STOCKTON MA, Giger K, Nyblade L
    A scoping review of the role of HIV-related stigma and discrimination in noncommunicable disease care.
    PLoS One. 2018;13:e0199602.
    PubMed     Text format     Abstract available
    
    
69. WONG CC, Lim SH, Tan CT, Lui SY, et al
    Performance of the HIV Blot 2.2, INNO-LIA HIV I/II Score, and Geenius HIV 1/2 Confirmatory Assay for use in HIV confirmation.
    PLoS One. 2018;13:e0199502.
    PubMed     Text format     Abstract available
    
    
70. VERONIKI AA, Antony J, Straus SE, Ashoor HM, et al
    Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs.
    PLoS One. 2018;13:e0198447.
    PubMed     Text format     Abstract available
    
    
71. LUMBANTORUAN C, Kermode M, Giyai A, Ang A, et al
    Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    PLoS One. 2018;13:e0198329.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Pathog

72. SHIN YC, Bischof GF, Lauer WA, Gonzalez-Nieto L, et al
    A recombinant herpesviral vector containing a near-full-length SIVmac239 genome produces SIV particles and elicits immune responses to all nine SIV gene products.
    PLoS Pathog. 2018;14:e1007143.
    PubMed     Text format     Abstract available
    
    
73. WANAGURU M, Barry DJ, Benton DJ, O'Reilly NJ, et al
    Murine leukemia virus p12 tethers the capsid-containing pre-integration complex to chromatin by binding directly to host nucleosomes in mitosis.
    PLoS Pathog. 2018;14:e1007117.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

74. VAN DUYNE R, Freed EO
    HIV-1 packs in PACSIN2 for cell-to-cell spread.
    Proc Natl Acad Sci U S A. 2018 Jun 20. pii: 1808821115.
    PubMed     Text format    
    
    

    
    Science

75. COHEN J
    Babies who dodge HIV may not be unscathed.
    Science. 2018;360:1168.
    PubMed     Text format    
    
    
76. ABDOOL KARIM Q, Abdool Karim SS
    HIV-No time for complacency.
    Science. 2018;360:1153.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: